Clinical Trials Browser

Phase 2 × Nasopharyngeal Carcinoma × Bortezomib × Clear all

NCT00367718 2020-05-18

Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma

Phase 2 Withdrawn

Nasopharyngeal Carcinoma